Search Results

FILTER BY

1 - 12 of 101 matches

Sort by:
  • PresentationACC 2025

    Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

    Presenter:  

    Hyo-Soo Kim

    March 29, 2025

  • PresentationTCT 2024

    3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

    Presenter:  

    Hongbo Yang

    October 30, 2024

  • PresentationTCT 2024

    TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

    Presenter:  

    Ryo Hikida

    October 29, 2024

  • PresentationTCT 2024

    TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

    Presenter:  

    IFTIKHAR CH

    October 27, 2024

  • PresentationTCT 2024

    TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention

    Presenter:  

    Yao Jiang

    October 27, 2024

  • PresentationTCT 2024

    TCT 289: Different Efficacy of 12-Month Dual Antiplatelet Therapy Following Off-Pump Versus On-Pump Coronary Artery Bypass Grafting

    Presenter:  

    Woo Jin Jang

    October 27, 2024

  • PresentationTCT 2023

    AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

    Presenter:  

    Edip Gurol

    October 26, 2023

  • PresentationTCT 2023

    TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

    Presenter:  

    Masaru Ishida

    October 26, 2023

  • PresentationTCT 2023

    TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

    Presenter:  

    Aakash Garg

    October 25, 2023

  • PresentationTCT 2023

    TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

    Presenter:  

    Jung-Hee Lee

    October 25, 2023

  • PresentationTCT 2023

    TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

    Presenter:  

    Seong Huan Choi

    October 25, 2023

  • PresentationTCT 2023

    TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

    Presenter:  

    Ji-Yeon Kim

    October 25, 2023